Clinical Trial Update: Estradiol Plus Olaparib for Breast Cancer (PHOEBE) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (PHOEBE) is testing estradiol in combination with olaparib for metastatic breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ESTRADIOL (Estradiol)
• Lynparza (olaparib)

Snippet

Sponsor: Mary D Chamberlin | Conditions: Metastatic Breast Cancer | Phase 1 | Status: RECRUITING